Fullerenol nanoparticles decrease ischaemia-induced brain injury and oedema through inhibition of oxidative damage and aquaporin-1 expression in ischaemic stroke

References

• Papadopoulos MC, Verkman AS. Aquaporin-4 and brain edema. Pediatr Nephrol. 2007;22:778–84.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Yanez M, Castellanos M, Blanco M, Mosquera E, Castillo J. Vascular protection in brain ischemia. Cerebrovasc Dis. 2006;21:21–9.
   PubMedGoogle Scholar
• Liu D, Zhang X, Hu B, Ander BP. Src Family kinases in brain edema after acute brain injury. Acta Neurochirurg Suppl. 2016;121:185–90.
   PubMedGoogle Scholar
• Qiu B, Li X, Sun X, Wang Y, Jing Z, Zhang X, Wang Y. Overexpression of aquaporin1 aggravates hippocampal damage in mouse traumatic brain injury models. Mol Med Rep. 2014;9:916–22.
   PubMed Web of Science ®Google Scholar
• Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. FEBS Lett. 2003;555:72–8.
   PubMed Web of Science ®Google Scholar
• Sepramaniam S, Armugam A, Lim KY, Karolina DS, Swaminathan P, Tan JR, Jeyaseelan K. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J Biol Chem 2010;17,285:29223–30.
   Web of Science ®Google Scholar
• Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57:178–201.
   PubMed Web of Science ®Google Scholar
• Kaneko K, Yagui K, Tanaka A, Yoshihara K, Ishikawa K, Takahashi K, Bujo H, Sakurai K, Saito Y. Aquaporin 1 is required for hypoxia-inducible angiogenesis in human retinal vascular endothelial cells. Microvasc Res. 2008;75:297–301.
   PubMed Web of Science ®Google Scholar
• Niizuma K, Yoshioka H, Chen H, Kim GS, Jung JE, Katsu M, Okami N, Chan PH. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys. 2010;1802:92–9.
   PubMed Web of Science ®Google Scholar
• Mohammadi MT, Dehghani GA. Nitric oxide as a regulatory factor for aquaporin-1 and 4 gene expression following brain ischemia/reperfusion injury in rat. Pathol Res Pract. 2015;211:43–9.
   PubMed Web of Science ®Google Scholar
• Heo JH, Han SW, Lee SK. Free radicals as triggers of brain edema formation after stroke. Free Rad Biol Med. 2005;39:51–70.
   PubMed Web of Science ®Google Scholar
• Alluri H, Stagg HW, Wilson RL, Clayton RP, Sawant DA, Koneru M, Beeram MR, Davis ML, Tharakan B. Reactive oxygen species-caspase-3 relationship in mediating blood–brain barrier endothelial cell hyperpermeability following oxygen-glucose deprivation and reoxygenation. Microcirculation. 2014;21:187–95.
   PubMed Web of Science ®Google Scholar
• Bioveris A, Chance B. The mitochondrial generation of hydrogen peroxide. Biochem J. 1973;134:707–16.
   PubMed Web of Science ®Google Scholar
• Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem. 2008;15:404–14.
   PubMed Web of Science ®Google Scholar
• Gill SS, Tuteja N. Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants. Plant Physiol Biochem. 2010;48:909–30.
   PubMed Web of Science ®Google Scholar
• Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cerebr Blood Flow Metabol. 2001;21:2–14.
   PubMed Web of Science ®Google Scholar
• Miller AA, Drummond GR, Sobey CG. Reactive oxygen species in the cerebral circulation: are they all bad? Antioxid Redox Signal. 2006;8:1113–20.
   PubMed Web of Science ®Google Scholar
• Ishizuka T, Niwa A, Tabuchi M, Ooshima K, Higashino H. Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in salt-loaded stroke-prone rats. Life Sci. 2008;82:806–15.
   PubMed Web of Science ®Google Scholar
• Kehrer JP. The Haber–Weiss reaction and mechanisms of toxicity. Toxicology. 2000;149:43–50.
   PubMed Web of Science ®Google Scholar
• Yoshioka H, Niizuma K, Katsu M, Okami N, Sakata H, Kim GS, Narasimhan P, Chan PH. NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cerebr Blood Flow Metabol. 2011;31:868–80.
   PubMed Web of Science ®Google Scholar
• Han F, Shirasaki Y, Fukunaga K. Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood–brain barrier in rat brain. J Neurochem. 2006;99:97–106.
   PubMed Web of Science ®Google Scholar
• Mohammadi MT, Shid-Moosavi SM, Dehghani GA. Contribution of nitric oxide synthase (NOS) activity in blood-brain barrier disruption and edema after acute ischemia/reperfusion in aortic coarctation-induced hypertensive rats. Iran Biomed J. 2011;15:22–30.
   PubMedGoogle Scholar
• Kroto HW, Allaf A, Balm S. C60: Buckminsterfullerene. Chem Rev. 1991;91:1213–35.
   Web of Science ®Google Scholar
• Lens M, Medenica L, Citernesi U. Antioxidative capacity of C60 (buckminsterfullerene) and newly synthesized fulleropyrrolidine derivatives encapsulated in liposomes. Biotechnol Appl Biochem. 2008;51:135–40.
   PubMed Web of Science ®Google Scholar
• Hosseini A, Sharifzadeh M, Rezayat SM, Hassanzadeh G, Hassani S, Baeeri M, Shetab-Bushehri V, Kuznetsov DA, Abdollahi M. Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy. Int J Nanomed. 2010;5:517.
   PubMed Web of Science ®Google Scholar
• Liao F, Saitoh Y, Miwa N. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts. Oncol Res Featur Preclin Clin Cancer Therapeut. 2011;19:203–16.
   Google Scholar
• Markovic Z, Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C 60). Biomaterials. 2008;29:3561–73.
   PubMed Web of Science ®Google Scholar
• Injac R, Prijatelj M, Strukelj B. Fullerenol nanoparticles: toxicity and antioxidant activity. Methods Mol Biol. 2013;1028:75–100.
   PubMedGoogle Scholar
• Kim YO, Kim HJ, Kim SK, Yoon B. Neuroprotective effects of hydroxyfullerene in rats subjected to global cerebral ischemia. Mol Cell Toxicol. 2008;4:218–23.
   Web of Science ®Google Scholar
• Chistyakov VA, Smirnova YO, Prazdnova EV, Soldatov AV. Possible mechanisms of fullerene C(6)(0) antioxidant action. BioMed Res Int. 2013;2013:821498.
   PubMed Web of Science ®Google Scholar
• Andrievsky GV, Bruskov VI, Tykhomyrov AA, Gudkov SV. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Rad Biol Med. 2009;47:786–93.
   PubMed Web of Science ®Google Scholar
• Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J. Polyhydroxylated fullerene derivative C60 (OH) 24 prevents mitochondrial dysfunction and oxidative damage in an MPP+‐induced cellular model of Parkinson’s disease. J Neurosci Res. 2008;86:3622–34.
   PubMed Web of Science ®Google Scholar
• Zha YY, Yang B, Tang ML, Guo QC, Chen JT, Wen LP, Wang M. Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability. Int J Nanomed. 2012;7:3099–109.
   PubMed Web of Science ®Google Scholar
• Hu Z, Huang Y, Guan W, Zhang J, Wang F, Zhao L. The protective activities of water-soluble C(60) derivatives against nitric oxide-induced cytotoxicity in rat pheochromocytoma cells. Biomaterials. 2010;31:8872–81.
   PubMed Web of Science ®Google Scholar
• Lin AM-Y, Fang S-F, Lin S-Z, Chou C-K, Luh T-Y, Ho L-T. Local carboxyfullerene protects cortical infarction in rat brain. Neurosci Res. 2002;43:317–21.
   PubMed Web of Science ®Google Scholar
• Fluri F, Grunstein D, Cam E, Ungethuem U, Hatz F, Schafer J, Samnick S, Israel I, Kleinschnitz C, Orts-Gil G, et al. Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Exp Neurol. 2015;265:142–51.
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke J Cerebr Circul. 1989;20:84–91.
   Web of Science ®Google Scholar
• Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A, Fisher M, Kaps M, Bachmann G. Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke. 2004;35:566–71.
   PubMed Web of Science ®Google Scholar
• Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.
   PubMed Web of Science ®Google Scholar
• Riahi S, Mohammadi MT, Sobhani V, Ababzadeh S. Chronic aerobic exercise decreases lectin-like low density lipoprotein (LOX-1) receptor expression in heart of diabetic rat. Iran Biomed J. 2016;20:26–32.
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Riahi S, Mohammadi MT, Sobhani V, Soleimany M. Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet. Iran J Basic Med Sci. 2015;18:805–12.
   PubMed Web of Science ®Google Scholar
• Deb P, Sharma S, Hassan KM. Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology. 2010;17:197–218.
   PubMedGoogle Scholar
• Markovic Z, Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials. 2008;29:3561–73.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Lao F, Fu PP, Wamer WG, Zhao Y, Wang PC, Qiu Y, Sun B, Xing G, Dong J, et al. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials. 2009;30:611–21.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Fernandez-Gajardo R, Gutierrez R, Matamala JM, Carrasco R, Miranda-Merchak A, Feuerhake W. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013;12:698–714.
   PubMed Web of Science ®Google Scholar
• Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal. 2011;14:1505–17.
   PubMed Web of Science ®Google Scholar
• Slemmer JE, Shacka JJ, Sweeney M, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem. 2008;15:404–14.
   PubMed Web of Science ®Google Scholar
• Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev. 2002;54:271–84.
   PubMed Web of Science ®Google Scholar
• Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 2010;8:e1000479.
   PubMed Web of Science ®Google Scholar
• Bisaglia M, Natalini B, Pellicciari R, Straface E, Malorni W, Monti D, Franceschi C, Schettini G. C3-fullero-tris-methanodicarboxylic acid protects cerebellar granule cells from apoptosis. J Neurochem. 2000;74:1197–204.
   PubMed Web of Science ®Google Scholar
• Misirkic MS, Todorovic-Markovic BM, Vucicevic LM, Janjetovic KD, Jokanovic VR, Dramicanin MD, Markovic ZM, Trajkovic VS. The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C(60)) nanoparticles. Biomaterials. 2009;30:2319–28.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Minami S, Itoh S, Shiraishi S, Yokoo H, Yanagita T, Uezono Y, Mohri M, Wada A. Aquaporin subtypes in rat cerebral microvessels. Neurosci Lett. 2001;297:163–6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tajkhorshid E. Nitric oxide conduction by the brain aquaporin AQP4. Proteins. 2010;78:661–70.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cohen J, Boron WF, Schulten K, Tajkhorshid E. Exploring gas permeability of cellular membranes and membrane channels with molecular dynamics. J Struct Biol. 2007;157:534–44.
   PubMed Web of Science ®Google Scholar
• Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A. Targets for vascular protection after acute ischemic stroke. Stroke 2004;35:2220–5.
   PubMed Web of Science ®Google Scholar